Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
2019 · Journal for ImmunoTherapy of Cancer · 140 citations
https://doi.org/10.1186/s40425-019-0635-8
W
Wei Xiao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
788
Papers
12.9K
Citations
50
h-index
273
i10-index
Wei Xiao is an academic researcher from Central Hospital of Wuhan. The author has contributed to research in topics: Chronic Obstructive Pulmonary Disease (COPD) Research & Cancer-related molecular mechanisms research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 50, co-authored 670 publications.
ORCID: 0000-0002-8426-9060Papers by this author
worksPregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation
2023 · Immunity · 119 citations
https://doi.org/10.1016/j.immuni.2023.01.015
Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
2016 · Oncogenesis · 84 citations
https://doi.org/10.1038/oncsis.2016.67
A bioenergetic shift is required for spermatogonial differentiation
2020 · Cell Discovery · 74 citations
https://doi.org/10.1038/s41421-020-0183-x
A single-cell transcriptomic landscape of mouse testicular aging
2022 · Journal of Advanced Research · 71 citations
https://doi.org/10.1016/j.jare.2022.12.007
SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism
2021 · Signal Transduction and Targeted Therapy · 55 citations
https://doi.org/10.1038/s41392-021-00749-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat